💡 Celebrating the International Day of Women and Girls in Science! 💡
February 11, 2025
Today, Pharmidex proudly honors the incredible contributions of women and girls in science who drive innovation, discovery, and progress in healthcare and beyond.
Their dedication, expertise, and passion are essential in shaping the future of drug discovery, development, and scientific breakthroughs.
We are committed to promoting diversity, inclusion, and equal opportunities, ensuring that the next generation of female scientists continues to thrive and make a lasting impact.
Let’s celebrate, support, and inspire more women and girls to pursue careers in science! 🌍🔬✨
#Pharmidex #WomenInScience #GirlsInSTEM #Innovation #DiversityInSTEM #ScienceForAll
Pharmidex team are delighted to participate in workshop on "Re-shaping UK life science commercialisation strategy" organised by The Research and Development Society on Wednesday 11th June, at Mereside, Alderley Park. If you are attending, please linkup with our colleague Mo Alavijeh who will be delighted to meet you. Jamie Phadke , Alderley Park #UKlifescience https://lnkd.in/e6uKsRcN
Martin Barrett , Head of Business Development, will attend the symposium on 10–13 June 2025 at Hotel Comwell Borupgaard, Denmark. The event gathers top European scientists to discuss drug discovery. Martin looks forward to connecting with academia, CROs, and pharma to explore collaborations and showcase Pharmidex’s services from in silico to in vivo pharmacology. Attending? Let’s connect! 🔗 https://lnkd.in/ev7TW7WG
We’re excited to announce our involvement in the recent publication: "Anti-Inflammatory Activity of Ensifentrine: A Novel, Selective Dual Inhibitor of PDE3 and PDE4" 📄 https://pubmed.ncbi.nlm.nih.gov/40245851/ 📄 https://www.pharmidex.com/publications-by-pharmidex Dr. Radhakrishnan Venkatasamy , our Senior Scientist in autoinflammatory and immune diseases, co-authored this study highlighting Ensifentrine’s anti-inflammatory potential. This reflects Pharmidex’s commitment to advancing therapies through expert science and collaboration.
